Improved Prognostic Value in Predicting Long-Term Cardiovascular Events by a Combination of High-Sensitivity

Hack-Lyoung Kim1, Woo-Hyun Lim1, Jae-Bin Seo1

  • 1Boramae Medical Center, Division of Cardiology, Department of Internal Medicine, Seoul National University College of Medicine, 5 Boramae-ro, Dongjak-gu, Seoul 07061, Korea.

Insights

Combining high-sensitivity C-reactive protein (hs-CRP) and brachial-ankle pulse wave velocity (baPWV) measurements improves cardiovascular risk prediction. This combined approach offers better stratification for major adverse cardiovascular events (MACE) than individual measures alone.

Area of Science:

  • Cardiology
  • Biomarkers
  • Vascular Health

Background:

  • C-reactive protein (CRP) and arterial stiffness are established risk factors for cardiovascular disease (CVD).
  • Current risk stratification models may not fully capture individual patient risk.
  • Investigating combined biomarkers can enhance CVD risk assessment.

Purpose of the Study:

  • To evaluate if combining high-sensitivity CRP (hs-CRP) and brachial-ankle pulse wave velocity (baPWV) improves cardiovascular risk stratification.
  • To assess the prognostic value of hs-CRP and baPWV, individually and in combination, for major adverse cardiovascular events (MACE).

Main Methods:

  • Retrospective analysis of 6572 subjects with hs-CRP and baPWV measurements.
  • Assessment of major adverse cardiovascular events (MACE) including cardiovascular death, myocardial infarction, revascularization, and stroke.
  • Statistical analysis to determine hazard ratios and prognostic value of combined markers.

Main Results:

  • Elevated baPWV (≥1505 cm/s) and hs-CRP (≥3 mg/L) were independently associated with increased MACE risk.
  • The combination of high baPWV and high hs-CRP significantly increased MACE risk (HR, 7.08).
  • Adding baPWV to clinical factors and hs-CRP improved prognostic value (global Chi-square from 126 to 167).

Conclusions:

  • The combined assessment of hs-CRP and baPWV offers superior prediction of future CVD events compared to individual measurements.
  • Simultaneous measurement of hs-CRP and baPWV is a clinically valuable tool for enhancing cardiovascular risk stratification.
  • This combined approach aids in identifying high-risk individuals for targeted interventions.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
272
Assessment of blood pressure in brachial artery(two-step method)01:23

Assessment of blood pressure in brachial artery(two-step method)

Measuring blood pressure is a fundamental skill in healthcare that aids in diagnosing and monitoring hypertension and other cardiovascular conditions. An aneroid sphygmomanometer, commonly used in clinical settings, offers a manual and precise method for blood pressure measurement. The technique for using this instrument involves specific steps that must be carefully executed to ensure accuracy. The following detailed description outlines a two-step technique for assessing blood pressure using...
1.0K
Assessment of blood pressure in brachial artery(one-step method)01:15

Assessment of blood pressure in brachial artery(one-step method)

This procedural guide systematically measures blood pressure using an oscillometric digital sphygmomanometer, emphasizing accuracy, patient safety, and comfort.
Prepare for the Procedure:
784
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
85